Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia

Christopher Hocking, Vy Tuong Broadbridge, Christos Karapetis, Carol Beeke, Robert Padbury, Guy J. Maddern, David M. Roder, Timothy J. Price

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To compare the management and outcome of rural and metropolitan patients with metastatic colorectal cancer (mCRC) in South Australia.

Design, setting and patients: Retrospective cohort study of patients with mCRC submitted to the South Australian mCRC registry between 2 February 2006 and a cut-off date of 28 May 2012.

Main outcome measures: Differences in oncological and surgical management and overall survival (calculated using the Kaplan–Meier method) between city and rural patients.

Results: Of 2289 patients, 624 (27.3%) were rural. There was a higher proportion of male patients in the rural cohort, but other patient characteristics did not significantly differ between the cohorts. Equivalent rates of chemotherapy administration between city and rural patients were observed across each line of treatment (first line: 56.0% v 58.3%, P = 0.32; second line: 23.3% v 22.5%, P = 0.78; and third line: 10.1% v 9.3%, P = 0.69). A higher proportion of city patients received combination chemotherapy in the first-line setting (67.4% v 59.9%; P = 0.01). When an oxaliplatin combination was prescribed, oral capecitabine was used more frequently in rural patients (22.9% v 8.4%; P < 0.001). No significant difference was seen in rates of hepatic resection or other non-chemotherapy treatments between cohorts. Median overall survival was equivalent between city and rural patients (14.6 v 14.9 months, P = 0.18).

Conclusion: Patterns of chemotherapy and surgical management of rural patients with mCRC in SA are equivalent to their metropolitan counterparts and lead to comparable overall survival. The centralised model of oncological care in SA may ensure rural patients gain access to optimal care.

LanguageEnglish
Pages462-466
Number of pages5
JournalMedical Journal of Australia
Volume201
Issue number8
DOIs
Publication statusPublished - 1 Jan 2014

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hocking, C., Broadbridge, V. T., Karapetis, C., Beeke, C., Padbury, R., Maddern, G. J., ... Price, T. J. (2014). Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia. Medical Journal of Australia, 201(8), 462-466. https://doi.org/10.5694/mja14.00046
Hocking, Christopher ; Broadbridge, Vy Tuong ; Karapetis, Christos ; Beeke, Carol ; Padbury, Robert ; Maddern, Guy J. ; Roder, David M. ; Price, Timothy J. / Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia. In: Medical Journal of Australia. 2014 ; Vol. 201, No. 8. pp. 462-466.
@article{a9d37df5cb4345db8a1ce8e7bcc01448,
title = "Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia",
abstract = "Objective: To compare the management and outcome of rural and metropolitan patients with metastatic colorectal cancer (mCRC) in South Australia.Design, setting and patients: Retrospective cohort study of patients with mCRC submitted to the South Australian mCRC registry between 2 February 2006 and a cut-off date of 28 May 2012.Main outcome measures: Differences in oncological and surgical management and overall survival (calculated using the Kaplan–Meier method) between city and rural patients.Results: Of 2289 patients, 624 (27.3{\%}) were rural. There was a higher proportion of male patients in the rural cohort, but other patient characteristics did not significantly differ between the cohorts. Equivalent rates of chemotherapy administration between city and rural patients were observed across each line of treatment (first line: 56.0{\%} v 58.3{\%}, P = 0.32; second line: 23.3{\%} v 22.5{\%}, P = 0.78; and third line: 10.1{\%} v 9.3{\%}, P = 0.69). A higher proportion of city patients received combination chemotherapy in the first-line setting (67.4{\%} v 59.9{\%}; P = 0.01). When an oxaliplatin combination was prescribed, oral capecitabine was used more frequently in rural patients (22.9{\%} v 8.4{\%}; P < 0.001). No significant difference was seen in rates of hepatic resection or other non-chemotherapy treatments between cohorts. Median overall survival was equivalent between city and rural patients (14.6 v 14.9 months, P = 0.18).Conclusion: Patterns of chemotherapy and surgical management of rural patients with mCRC in SA are equivalent to their metropolitan counterparts and lead to comparable overall survival. The centralised model of oncological care in SA may ensure rural patients gain access to optimal care.",
author = "Christopher Hocking and Broadbridge, {Vy Tuong} and Christos Karapetis and Carol Beeke and Robert Padbury and Maddern, {Guy J.} and Roder, {David M.} and Price, {Timothy J.}",
year = "2014",
month = "1",
day = "1",
doi = "10.5694/mja14.00046",
language = "English",
volume = "201",
pages = "462--466",
journal = "The Medical journal of Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Co. Ltd",
number = "8",

}

Hocking, C, Broadbridge, VT, Karapetis, C, Beeke, C, Padbury, R, Maddern, GJ, Roder, DM & Price, TJ 2014, 'Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia', Medical Journal of Australia, vol. 201, no. 8, pp. 462-466. https://doi.org/10.5694/mja14.00046

Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia. / Hocking, Christopher; Broadbridge, Vy Tuong; Karapetis, Christos; Beeke, Carol; Padbury, Robert; Maddern, Guy J.; Roder, David M.; Price, Timothy J.

In: Medical Journal of Australia, Vol. 201, No. 8, 01.01.2014, p. 462-466.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia

AU - Hocking, Christopher

AU - Broadbridge, Vy Tuong

AU - Karapetis, Christos

AU - Beeke, Carol

AU - Padbury, Robert

AU - Maddern, Guy J.

AU - Roder, David M.

AU - Price, Timothy J.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: To compare the management and outcome of rural and metropolitan patients with metastatic colorectal cancer (mCRC) in South Australia.Design, setting and patients: Retrospective cohort study of patients with mCRC submitted to the South Australian mCRC registry between 2 February 2006 and a cut-off date of 28 May 2012.Main outcome measures: Differences in oncological and surgical management and overall survival (calculated using the Kaplan–Meier method) between city and rural patients.Results: Of 2289 patients, 624 (27.3%) were rural. There was a higher proportion of male patients in the rural cohort, but other patient characteristics did not significantly differ between the cohorts. Equivalent rates of chemotherapy administration between city and rural patients were observed across each line of treatment (first line: 56.0% v 58.3%, P = 0.32; second line: 23.3% v 22.5%, P = 0.78; and third line: 10.1% v 9.3%, P = 0.69). A higher proportion of city patients received combination chemotherapy in the first-line setting (67.4% v 59.9%; P = 0.01). When an oxaliplatin combination was prescribed, oral capecitabine was used more frequently in rural patients (22.9% v 8.4%; P < 0.001). No significant difference was seen in rates of hepatic resection or other non-chemotherapy treatments between cohorts. Median overall survival was equivalent between city and rural patients (14.6 v 14.9 months, P = 0.18).Conclusion: Patterns of chemotherapy and surgical management of rural patients with mCRC in SA are equivalent to their metropolitan counterparts and lead to comparable overall survival. The centralised model of oncological care in SA may ensure rural patients gain access to optimal care.

AB - Objective: To compare the management and outcome of rural and metropolitan patients with metastatic colorectal cancer (mCRC) in South Australia.Design, setting and patients: Retrospective cohort study of patients with mCRC submitted to the South Australian mCRC registry between 2 February 2006 and a cut-off date of 28 May 2012.Main outcome measures: Differences in oncological and surgical management and overall survival (calculated using the Kaplan–Meier method) between city and rural patients.Results: Of 2289 patients, 624 (27.3%) were rural. There was a higher proportion of male patients in the rural cohort, but other patient characteristics did not significantly differ between the cohorts. Equivalent rates of chemotherapy administration between city and rural patients were observed across each line of treatment (first line: 56.0% v 58.3%, P = 0.32; second line: 23.3% v 22.5%, P = 0.78; and third line: 10.1% v 9.3%, P = 0.69). A higher proportion of city patients received combination chemotherapy in the first-line setting (67.4% v 59.9%; P = 0.01). When an oxaliplatin combination was prescribed, oral capecitabine was used more frequently in rural patients (22.9% v 8.4%; P < 0.001). No significant difference was seen in rates of hepatic resection or other non-chemotherapy treatments between cohorts. Median overall survival was equivalent between city and rural patients (14.6 v 14.9 months, P = 0.18).Conclusion: Patterns of chemotherapy and surgical management of rural patients with mCRC in SA are equivalent to their metropolitan counterparts and lead to comparable overall survival. The centralised model of oncological care in SA may ensure rural patients gain access to optimal care.

UR - http://www.scopus.com/inward/record.url?scp=84919362643&partnerID=8YFLogxK

U2 - 10.5694/mja14.00046

DO - 10.5694/mja14.00046

M3 - Article

VL - 201

SP - 462

EP - 466

JO - The Medical journal of Australia

T2 - The Medical journal of Australia

JF - The Medical journal of Australia

SN - 0025-729X

IS - 8

ER -